Pay in 4 interest-free payments of $22.31 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
To evaluate whether the reactive oxygen species (ROS)-inducing IKKβ inhibitor increases the sensitivity of melanoma cells to nitrosourea
PROTAC Sirt2 Degrader-1 (Compound 12
Nucleophosmin Regulates Intracellular Oxidative Stress Homeostasis via Antioxidant PRDX6
InChi: InChI=1S/C38H69NO13/c1-15-26-38(10
5 μM after 24 and 48 h of treatment
Lapatinib Size:Solid 10 mg To evaluate whether the reactiveLapatinib is a synthetic, orally active quinazoline with potential antineoplastic activity. Lapatinib reversibly blocks phosphorylation of the epidermal growth factor receptor (EGFR), ErbB2, and the Erk 1 and 2 and AKT kinases; it also inhibits cyclin D protein levels in human tumor cell lines and xenografts. EGFR and ErbB2 have been implicated in the growth of various tumor types. Check for active clinical trials or closed clinical trials using this
US$ 9450.00
US$ 9450.00
US$ 6000.00
US$ 12550.00
US$ 13400.00
US$ 10920.00
US$ 24300.00
US$ 6200.00